Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?
about
NMDA receptor activity downregulates KCC2 resulting in depolarizing GABAA receptor-mediated currentsA conceptual framework for the use of neuroimaging to study and predict pharmacoresistance in epilepsyDiagnostic methods and treatment options for focal cortical dysplasiaIncreased GABAergic inhibition in the midline thalamus affects signaling and seizure spread in the hippocampus-prefrontal cortex pathway.Pharmacoresistance and the role of surgery in difficult to treat epilepsy.Focal cortical dysplasia: prevalence, clinical presentation and epilepsy in children and adults.Anomalous expression of chloride transporters in the sclerosed hippocampus of mesial temporal lobe epilepsy patientsEffectiveness of first antiepileptic drug.Is refractory epilepsy preventable?Epilepsy imaging study guideline criteria: commentary on diagnostic testing study guidelines and practice parameters.A Greater Role for Surgical Treatment of Epilepsy: Why and When?Long-term outcome of nonsurgical candidates with medically refractory localization-related epilepsy.Medical intractability and imaging: can MRI predict the future?A population-based study of long-term outcome of epilepsy in childhood with a focal or hemispheric lesion on neuroimagingBrain arteriovenous malformations and endovascular treatment: effect on seizures.Mapping a mouse limbic seizure susceptibility locus on chromosome 10Drug resistance in epilepsy: putative neurobiologic and clinical mechanisms.Characterization of the gene expression profile of human hippocampus in mesial temporal lobe epilepsy with hippocampal sclerosis.Cause of death in patients with poststroke epilepsy: Results from a nationwide cohort studyRefractory epilepsy: mechanisms and solutions.PET tracer technology for monitoring focal epilepsies.Effect of valproic acid on seizure control and on survival in patients with glioblastoma multiforme.Use of chromosome substitution strains to identify seizure susceptibility loci in mice.The mortality and morbidity of febrile seizures.The influence of design and definition on the proportion of general epilepsy cohorts with remission and intractability.The somatic comorbidity of epilepsy: a weighty but often unrecognized burden.Electroencephalography in mesial temporal lobe epilepsy: a reviewReduced astrocytic contribution to the turnover of glutamate, glutamine, and GABA characterizes the latent phase in the kainate model of temporal lobe epilepsy.Comparative effectiveness of antiepileptic drugs in patients with mesial temporal lobe epilepsy with hippocampal sclerosis.Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.Factors predicting the outcome following surgical treatment of mesial temporal epilepsy due to mesial temporal sclerosis.Seizures and Brain Arterovenous Malformation: A Surgical Series.The role of underlying structural cause for epilepsy classification: clinical features and prognosis in mesial temporal lobe epilepsy caused by hippocampal sclerosis versus cavernoma.Response to Early AED Therapy and Its Prognostic Implications.Is epilepsy intractability predetermined or acquired?Changing channels: mechanisms and responsiveness to antiepileptic drugs in chronic epilepsy.Drug resistance in epilepsy: is the role of underlying pathology related to multidrug resistance protein?Characterization of the tetanus toxin model of refractory focal neocortical epilepsy in the rat.Topiramate in long-term treatment of epilepsy in the intellectually disabled.Comment on Epilepsy in cerebrovascular diseases: Review of experimental and clinical data with meta-analysis of risk factors.
P2860
Q24630525-4354CAB2-B1B1-4834-B399-BC8966C84D0EQ27006619-FD73B7F6-65C7-486A-AD05-327874F1EE39Q28081144-33B7D1E9-CA0D-4057-BCCF-B8EE9C6612E2Q30428066-2CCFC559-E607-4F3D-9DCE-A848D52881E5Q33161739-ED25B864-6599-42CB-96F4-A8FD3D1D9C68Q33231589-E7C11826-DB70-4B31-8E22-FE3FB9DDCBFDQ34095263-A52E1025-C6ED-442A-8D9C-D407650C7BD0Q34104380-74795204-DB55-4DA3-B908-BFE57940529CQ34123660-A1D0266F-A36C-404A-9A77-D18099BEAD05Q35204659-89A2331C-0E65-434A-A966-6C7007E917BEQ35537454-A6677024-2399-4889-A0B9-C4315573183CQ35592475-70E30F58-41EA-4F8D-A71C-E2FACD2478E1Q35612522-404729BB-9B38-4B28-8A3F-B23645FA65BEQ35630379-D9FD5BED-CD3D-41A2-8FB4-2AEAA802F74EQ35752313-7E528A7E-D8EC-4FE1-BB5A-CD2CC300E41DQ35940537-6FBD8620-D966-403C-81BB-C8EC33042162Q36157234-344A9BC4-1B80-4E11-8318-1B6D5F825ECDQ36192452-7279EC5B-F1CE-46F9-B882-8EA6C5BCBB2EQ36335924-966A47A4-3DA4-4C67-8C87-B139F0DD9BC3Q36419584-909B3A7A-EC10-4EB3-A838-F26A160154A1Q36759514-B39C2514-8A36-4256-92BA-294138CBF4D4Q36943913-167A3932-46C6-4AB3-B2AA-1B3D0971CC2CQ37094135-26DD985D-95C1-4393-A50F-13F3AAB7D976Q37315452-AA38CFEE-A21B-403D-9E7C-9FD8FB6FEEA3Q37878795-A3FDA736-CFDE-43BB-9FD4-85D9789159F2Q38018125-0AE503B8-BBA0-487C-BD31-9F34FA73C6AAQ38041552-7F3D2CEE-BFB3-40EC-A7E1-0FD3CC8BFB87Q38370011-D86D9952-4D97-49B9-9E23-6DCC11A3FC26Q38600646-8E843B14-04AE-4B9D-ADBB-5A33381EF79AQ38746272-30248424-01F7-48FC-99EB-5E27E70CAB04Q38988033-64043BD8-64AA-499C-996E-E9DFB81B8974Q39380713-3CAF026F-57E3-45FB-93C4-109C7EDCD41CQ39769081-5A393103-BAF5-4EA6-9D8D-61CB162AD7E0Q40466387-7E7103C0-0809-406F-8427-3FE1DD6F94CEQ42119344-4EDB4BFD-A5CD-4ABE-B50D-2A3D9C4ED192Q42151890-D67381EB-4856-41CC-AADB-CE3D8FAB5B91Q42921644-6D6C90A9-3FF0-4A7A-BB3C-7228D645FB06Q45243582-ECBD47F6-D492-4C53-A4B6-5E46AD17DD2DQ45266638-12D8D298-EE64-4331-9B81-21DD13C32A8DQ45984922-42B8B49A-71BF-4E7F-B9F7-CD637612E68B
P2860
Does the cause of localisation-related epilepsy influence the response to antiepileptic drug treatment?
description
2001 nî lūn-bûn
@nan
2001年の論文
@ja
2001年学术文章
@wuu
2001年学术文章
@zh
2001年学术文章
@zh-cn
2001年学术文章
@zh-hans
2001年学术文章
@zh-my
2001年学术文章
@zh-sg
2001年學術文章
@yue
2001年學術文章
@zh-hant
name
Does the cause of localisation ...... antiepileptic drug treatment?
@en
Does the cause of localisation ...... antiepileptic drug treatment?
@nl
type
label
Does the cause of localisation ...... antiepileptic drug treatment?
@en
Does the cause of localisation ...... antiepileptic drug treatment?
@nl
prefLabel
Does the cause of localisation ...... antiepileptic drug treatment?
@en
Does the cause of localisation ...... antiepileptic drug treatment?
@nl
P2860
P1433
P1476
Does the cause of localisation ...... antiepileptic drug treatment?
@en
P2093
P2860
P304
P356
10.1046/J.1528-1157.2001.29000.X
P50
P577
2001-03-01T00:00:00Z